Capricor Therapeutics (CAPR) Accumulated Depreciation & Amortization (2018 - 2025)
Historic Accumulated Depreciation & Amortization for Capricor Therapeutics (CAPR) over the last 12 years, with Q3 2025 value amounting to $4.6 million.
- Capricor Therapeutics' Accumulated Depreciation & Amortization rose 4346.48% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 4346.48%. This contributed to the annual value of $3.5 million for FY2024, which is 5639.03% up from last year.
- Per Capricor Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $4.6 million for Q3 2025, which was up 4346.48% from $4.2 million recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' Accumulated Depreciation & Amortization registered a high of $4.6 million during Q3 2025, and its lowest value of $756712.0 during Q4 2021.
- Over the past 5 years, Capricor Therapeutics' median Accumulated Depreciation & Amortization value was $1.6 million (recorded in 2023), while the average stood at $2.1 million.
- As far as peak fluctuations go, Capricor Therapeutics' Accumulated Depreciation & Amortization skyrocketed by 530.66% in 2021, and later soared by 8669.67% in 2023.
- Over the past 5 years, Capricor Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $756712.0 in 2021, then skyrocketed by 56.15% to $1.2 million in 2022, then soared by 86.7% to $2.2 million in 2023, then skyrocketed by 56.39% to $3.5 million in 2024, then soared by 34.72% to $4.6 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $4.6 million for Q3 2025, versus $4.2 million for Q2 2025 and $3.7 million for Q1 2025.